ERIS Lifesciences News

Eris Lifesciences appoints Akhil Awasthi as director

Eris Lifesciences has appointed investment veteran Akhil Awasthi as an additional independent director for a five-year term effective September 26, 2026.

Eris Lifesciences accepts COO resignation

Eris Lifesciences has accepted the resignation of Krishnakumar Vaidyanathan as Executive Director and COO. He will step down on September 30, 2026, to pursue other professional opportunities.

Eris Lifesciences secures ₹45 crore term loan from Axis Bank

Eris Lifesciences has entered into a term loan agreement with Axis Bank for ₹45 crore to meet other liabilities. The company states this routine adjustment will not impact its expected net debt figure at the end of the quarter.

Eris Lifesciences to host analyst meet on Aug 4

Eris Lifesciences Limited will hold a virtual one-on-one meeting with Bandhan Mutual Fund on August 4, 2026, at 4:00 PM IST. Management will discuss publicly available information only.

Eris Lifesciences to host Q1 FY27 earnings call

Eris Lifesciences will hold an analyst call on July 29, 2026, to discuss Q1 FY27 results. The meeting follows the Board's review of unaudited financials.